FIGURE
Fig. 2
- ID
- ZDB-FIG-110718-13
- Publication
- Becker et al., 2011 - Human cardiomyopathy mutations induce myocyte hyperplasia and activate hypertrophic pathways during cardiogenesis in zebrafish
- Other Figures
- All Figure Page
- Back to All Figure Page
Fig. 2
TNNT2sp morphants have reduced ventricular dimensions and impaired ventricular function. (A) Comparison of control-injected (top) and TNNT2sp morphant (bottom) embryos at 96 hpf. (B) Representative high-magnification image of control (left) and TNNT2sp morphant (right) heart (A, atria; V, ventricle; atria not visible in control). (C) Chamber dimensions in control (black bar) and TNNT2sp morphants (gray bar). (D) FS in control (black bar) and TNNT2sp morphants (gray bar). *P<0.05; n=5 for all measurements. All data expressed as mean + s.e.m. |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
| Fish: | |
|---|---|
| Knockdown Reagent: | |
| Observed In: | |
| Stage: | Day 4 |
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Dis. Model. Mech.